Plasmin(ogen) at the Nexus of Fibrinolysis, Inflammation, and Complement

Seminars in Thrombosis and Hemostasis

Volumn 43, Issue 2, 2017, Pages 135-142

  Foley, Jonathan H ^a,b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

complement; fibrinolysis; inflammation; plasminogen receptors; wound healing

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BINDING PROTEIN; COMPLEMENT; COMPLEMENT INHIBITOR; CPB2 PROTEIN; FIBRIN; FIBRINOLYTIC FACTOR; LIPOCORTIN 2; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN RECEPTOR; PLASMINOGEN[LYSINE]; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CYTOTOXIC T LYMPHOCYTE; FIBRINOLYSIS; HUMAN; IMMUNE EVASION; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN FUNCTION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

COMPLEMENT SYSTEM PROTEINS; FIBRINOLYSIS; HUMANS; INFLAMMATION; PLASMINOGEN; WOUND HEALING;

EID: 85008316411     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1592302     Document Type: Article

References (86)

1. Levin E G Marzec U Anderson J Harker L A Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells J Clin Invest 1984 74 6 1988 1995
2. Shatos M A Orfeo T Doherty J M Penar P L Collen D Mann K G Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells Arterioscler Thromb Vasc Biol 1995 15 7 903 911
3. Kim P Y Tieu L D Stafford A R Fredenburgh J C Weitz J I A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator J Biol Chem 2012 287 7 4652 4661
4. Horrevoets A J Pannekoek H Nesheim M E A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]-and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain J Biol Chem 1997 272 4 2183 2191
5. Walker J B Nesheim M E A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size J Biol Chem 2001 276 5 3138 3148
6. Lijnen H R Zamarron C Blaber M Winkler M E Collen D Activation of plasminogen by pro-urokinase. I. Mechanism J Biol Chem 1986 261 3 1253 1258
7. Miles L A Greengard J S Griffin J H A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen Thromb Res 1983 29 4 407 417
8. de Maat S Björkqvist J Suffritti C, et al. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations J Allergy Clin Immunol 2016 138 5 1414 1423.e9
9. Foley J H Cook P F Nesheim M E Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites J Biol Chem 2011 286 22 19280 19286
10. Godier A Hunt B J Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease J Thromb Haemost 2013 11 1 26 34
11. Plow E F Herren T Redlitz A Miles L A Hoover-Plow J L The cell biology of the plasminogen system FASEB J 1995 9 10 939 945
12. Ditzel H J Strik M C Larsen M K, et al. Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomas J Biol Chem 2002 277 24 21712 21722
13. Seipelt J Liebig H D Sommergruber W Gerner C Kuechler E 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells J Biol Chem 2000 275 26 20084 20089
14. Vaisar T Kassim S Y Gomez I G, et al. MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages Mol Cell Proteomics 2009 8 5 1044 1060
15. Jevnikar Z Obermajer N Doljak B, et al. Cathepsin X cleavage of the beta2 integrin regulates talin-binding and LFA-1 affinity in T cells J Leukoc Biol 2011 90 1 99 109
16. Deora A B Kreitzer G Jacovina A T Hajjar K A An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface J Biol Chem 2004 279 42 43411 43418
17. MacLeod T J Kwon M Filipenko N R Waisman D M Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin J Biol Chem 2003 278 28 25577 25584
18. Kassam G Le B H Choi K S, et al. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation Biochemistry 1998 37 48 16958 16966
19. Swisher J F Khatri U Feldman G M Annexin A2 is a soluble mediator of macrophage activation J Leukoc Biol 2007 82 5 1174 1184
20. Pancholi V Multifunctional alpha-enolase: its role in diseases Cell Mol Life Sci 2001 58 7 902 920
21. Das R Burke T Plow E F Histone H2B as a functionally important plasminogen receptor on macrophages Blood 2007 110 10 3763 3772
22. Das R Burke T Van Wagoner D R Plow E F L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages Circ Res 2009 105 2 167 175
23. Das R Plow E F Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, histone H2B, to the macrophage surface J Thromb Haemost 2011 9 2 339 349
24. Andronicos N M Chen E I Baik N, et al. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation Blood 2010 115 7 1319 1330
25. Abdul S Leebeek F W Rijken D C Uitte de Willige S Natural heterogeneity of α2-antiplasmin: functional and clinical consequences Blood 2016 127 5 538 545
26. Hall S W Humphries J E Gonias S L Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin J Biol Chem 1991 266 19 12329 12336
27. Schneider M Nesheim M A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis J Biol Chem 2004 279 14 13333 13339
28. Wu C Kim P Y Swystun L L Liaw P C Weitz J I Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells J Thromb Haemost 2016 14 2 366 374
29. Redlitz A Tan A K Eaton D L Plow E F Plasma carboxypeptidases as regulators of the plasminogen system J Clin Invest 1995 96 5 2534 2538
30. Wygrecka M Marsh L M Morty R E, et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung Blood 2009 113 22 5588 5598
31. Schlechte W Murano G Boyd D Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation Cancer Res 1989 49 21 6064 6069
32. Jimenez J J Iribarren J L Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial Crit Care 2007 11 6 R117
33. Jiménez J J Iribarren J L Brouard M, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial J Cardiothorac Surg 2011 6 138
34. Later A F Sitniakowsky L S van Hilten J A, et al. Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery J Thorac Cardiovasc Surg 2013 145 6 1611 1616, 1616.e1-1616.e4
35. Greilich P E Brouse C F Whitten C W Chi L Dimaio J M Jessen M E Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin J Thorac Cardiovasc Surg 2003 126 5 1498 1503
36. Graham E M Atz A M Gillis J, et al. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery J Thorac Cardiovasc Surg 2012 143 5 1069 1076
37. Renckens R Weijer S de Vos A F, et al. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia Arterioscler Thromb Vasc Biol 2004 24 3 483 488
38. Del Rosso M Fibbi G Pucci M Margheri F Serrati S The plasminogen activation system in inflammation Front Biosci 2008 13 4667 4686
39. Romer J Bugge T H Pyke C, et al. Impaired wound healing in mice with a disrupted plasminogen gene Nat Med 1996 2 3 287 292
40. Yuasa M Mignemi N A Nyman J S, et al. Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification J Clin Invest 2015 125 8 3117 3131
41. Li J Ny A Leonardsson G Nandakumar K S Holmdahl R Ny T The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis Am J Pathol 2005 166 3 783 792
42. Kremen M Krishnan R Emery I, et al. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice Proc Natl Acad Sci U S A 2008 105 44 17109 17114
43. Kwaan H C McMahon B The role of plasminogen-plasmin system in cancer Cancer Treat Res 2009 148 43 66
44. Syrovets T Jendrach M Rohwedder A Schüle A Simmet T Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation Blood 2001 97 12 3941 3950
45. Burysek L Syrovets T Simmet T The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways J Biol Chem 2002 277 36 33509 33517
46. Weide I Tippler B Syrovets T Simmet T Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes Thromb Haemost 1996 76 4 561 568
47. Syrovets T Tippler B Rieks M Simmet T Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway Blood 1997 89 12 4574 4583
48. Tarui T Majumdar M Miles L A Ruf W Takada Y Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin J Biol Chem 2002 277 37 33564 33570
49. Laumonnier Y Syrovets T Burysek L Simmet T Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes Blood 2006 107 8 3342 3349
50. Li X Syrovets T Genze F, et al. Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response Arterioscler Thromb Vasc Biol 2010 30 3 582 590
51. Borg R J Samson A L Au A E, et al. Dendritic cell-mediated phagocytosis but not immune activation is enhanced by plasmin PLoS ONE 2015 10 7 e0131216
52. Shen Y Guo Y Du C Wilczynska M Hellström S Ny T Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations PLoS ONE 2012 7 12 e51303
53. Lund L R Green K A Stoop A A, et al. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice EMBO J 2006 25 12 2686 2697
54. Shen Y Guo Y Mikus P, et al. Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds Blood 2012 119 24 5879 5887
55. Carmeliet P Moons L Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat Genet 1997 17 4 439 444
56. Ajjan R A Gamlen T Standeven K F, et al. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity Blood 2013 122 1 134 142
57. Ross R Atherosclerosis - an inflammatory disease N Engl J Med 1999 340 2 115 126
58. Viola J Soehnlein O Atherosclerosis - a matter of unresolved inflammation Semin Immunol 2015 27 3 184 193
59. Tkachuk V Stepanova V Little P J Bobik A Regulation and role of urokinase plasminogen activator in vascular remodelling Clin Exp Pharmacol Physiol 1996 23 9 759 765
60. Hu J H Du L Chu T, et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice Circulation 2010 121 14 1637 1644
61. Hu J H Touch P Zhang J, et al. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor Cardiovasc Res 2015 105 3 372 382
62. Foley J H Walton B L Aleman M M, et al. Complement activation in arterial and venous thrombosis is mediated by plasmin EBioMedicine 2016 5 175 182
63. Amara U Flierl M A Rittirsch D, et al. Molecular intercommunication between the complement and coagulation systems J Immunol 2010 185 9 5628 5636
64. Barthel D Schindler S Zipfel P F Plasminogen is a complement inhibitor J Biol Chem 2012 287 22 18831 18842
65. Bajic G Degn S E Thiel S Andersen G R Complement activation, regulation, and molecular basis for complement-related diseases EMBO J 2015 34 22 2735 2757
66. Huber-Lang M Sarma J V Zetoune F S, et al. Generation of C5a in the absence of C3: a new complement activation pathway Nat Med 2006 12 6 682 687
67. Castiblanco-Valencia M M Fraga T R Pagotto A H, et al. Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: A new role of LigA and LigB in invasion and complement immune evasion Immunobiology 2016 221 5 679 689
68. Agrahari G Liang Z Glinton K Lee S W Ploplis V A Castellino F J Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria J Biol Chem 2016 291 17 9181 9189
69. Sodeinde O A Subrahmanyam Y V Stark K Quan T Bao Y Goguen J D A surface protease and the invasive character of plague Science 1992 258 (5084): 1004 1007
70. Koch T K Reuter M Barthel D, et al. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b PLoS ONE 2012 7 10 e47638
71. Barthel D Singh B Riesbeck K Zipfel P F Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity J Immunol 2012 188 1 379 385
72. Degen J L Bugge T H Goguen J D Fibrin and fibrinolysis in infection and host defense J Thromb Haemost 2007 5 01 24 31
73. Lambris J D Ricklin D Geisbrecht B V Complement evasion by human pathogens Nat Rev Microbiol 2008 6 2 132 142
74. Shao Z Nishimura T Leung L L Morser J Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model J Thromb Haemost 2015 13 6 1090 1102
75. Song J J Hwang I Cho K H, et al; Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis (CLEAR) Registry. Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis J Clin Invest 2011 121 9 3517 3527
76. Myles T Nishimura T Yun T H, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation J Biol Chem 2003 278 51 51059 51067
77. Nishimura T Myles T Piliponsky A M Kao P N Berry G J Leung L L Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo Blood 2007 109 5 1992 1997
78. Ward P A A plasmin-split fragment of C'3 as a new chemotactic factor J Exp Med 1967 126 2 189 206
79. Foley J H Peterson E A Lei V Wan L W Krisinger M J Conway E M Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses J Thromb Haemost 2015 13 4 610 618
80. Wojta J Kaun C Zorn G, et al. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils Blood 2002 100 2 517 523
81. Kastl S P Speidl W S Kaun C, et al. The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation J Thromb Haemost 2006 4 8 1790 1797
82. Howes J M Richardson V R Smith K A, et al. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties Diab Vasc Dis Res 2012 9 3 216 225
83. Hess K Alzahrani S H Mathai M, et al. A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3 Diabetologia 2012 55 4 1103 1113
84. Hess K Alzahrani S H Price J F, et al. Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3 Diabetologia 2014 57 8 1737 1741
85. Nikolajsen C L Scavenius C Enghild J J Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades Biochemistry 2012 51 23 4735 4742
86. Richardson V R Schroeder V Grant P J Standeven K F Carter A M Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation Br J Haematol 2013 160 1 116 119